# US 2016/0355503 A1 · NITROGEN HEXACYCLE COMPOUNDS AS INHIBITORS OF p97 COMPLEX

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0355503 A1
- Document ID: US20160355503A1
- Status: Published application
- Kind: A1
- Application number: 15/173,294
- Filed: 2016-06-03
- Published: 2016-12-08
- Earliest claimed: 2015-06-04
- Assignees: Cleave Biosciences, Inc.
- Applicants: Cleave Biosciences, Inc.
- Inventors: Han-Jie Zhou; David Wustrow
- Web page: https://patentgrep.com/patent/US20160355503A1

## CPC

- C07D 403/04: directly linked by a ring-member-to-ring-member bond
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)

## Abstract

Nitrogen hexacycle compounds having an arylalkyl amine substituent at the P4 position and a substituted 5:6 bicyclic group at the P2 position of the nitrogen hexacycle as well as optional aliphatic, functional and/or aromatic components substituted at other positions of the nitrogen hexacycle, the aryl alkyl group and the 5:6 bicyclic group are disclosed. These compounds are inhibitors of the AAA proteasome complex containing p97 and are effective medicinal agents for treatment of diseases associated with p97 bioactivity such as cancer.

## Claims

### Claim 1

A nitrogen hexacycle compound of Formula I
Wherein:
One of X and Y is nitrogen and the other is CR2;
One of O1 and Q2 is nitrogen and the other is CR2′, or both of Q1 and Q2 are nitrogen;
The bicyclic ADEGZ group is a P2 group;
The five member ring of the P2 group is partially saturated or aromatic;
The six member ring of the P2 group is aromatic;
A, D and E each are independently C or nitrogen, the carbon of C being an sp2 carbon and A additionally may be CR6, the carbon of CR6 being an sp3 carbon;
The squiggle bond between D and E is a single bond if one of either of D and E is nitrogen, and the squiggle bond between D and E is a double bond if both of D and E are carbon;
The dotted bonds of the five member ring may be single or double bonds depending upon the valence and electon configuration of the bonded atom(s).
G and Z are each independently nitrogen, NR3, CR4, C(R5)2, oxygen or sulfur, the carbon of CR4 being an sp2 carbon and the carbon of C(R5)2 being an sp3 carbon, provided that:
when one of G and Z is oxygen or sulfur, each of A, D and E is an sp2 carbon;
G and Z are not together a combination of oxygen and sulfur and are not both oxygen or both sulfur;
when G and Z are both C(R5)2, A is CR6 or N and D and E are both sp2 carbons;
when G and Z are both CR4, A is CR6 or N and D and E are both sp2 carbons;
R1 is selected from hydrogen, an aliphatic group optionally substituted by a functional group or a functional group;
R2, R2′, Rn, R4 and each of R5 are each independently selected from hydrogen, an aliphatic group optionally substituted by a functional group, an optionally substituted aromatic group and a functional group with one of R5 preferably being hydrogen;
R3 is hydrogen, an aliphatic group optionally substituted by a functional group and a functional group;
R6 is hydrogen or an alkyl group of 1 to 3 carbons;
n is 0 or an integer of 1 or 2;
Ar is an aryl group optionally substituted by a functional group or an aliphatic group;
The number of boronic acid or boronic ester groups bonded anywhere to Formula I is one, the boronic acid and boronic ester groups being specific groups of a functional group.

### Claim 2 (depends on 1)

A nitrogen hexacycle compound according to claim 1 wherein A is nitrogen, G is CR4, D and E are sp2 carbon, and Z is nitrogen or CR4.

### Claim 3 (depends on 1)

A nitrogen hexacycle compound according to claim 1 wherein A and G both are nitrogen, D and E both are sp2 carbon, and Z is nitrogen or CR4.

### Claim 4 (depends on 1)

A nitrogen hexacycle compound according to claim 1 wherein A, D and E all are sp2 carbon, G is NR3 or oxygen and Z is CR4

### Claim 5 (depends on 1)

A nitrogen hexacycle compound according to claim 1 wherein A, D and E all are sp2 carbon, G is NR3 or oxygen and Z is nitrogen.

### Claim 6 (depends on 1)

A nitrogen hexacycle compound according to claim 1 wherein G and E both are nitrogen and A and D are both sp2 carbon.

### Claim 7 (depends on 1)

A nitrogen hexacycle compound according to claim 1 wherein G and D are nitrogen and A and E are both sp2 carbon.

### Claim 8 (depends on 1)

A nitrogen hexacycle compound according to claim 1 wherein Z and G are both CR4 or C(R5)2, A is CR6 or N and D and E are both sp2 carbon.

### Claim 9 (depends on 1)

A nitrogen hexacycle compound according to claim 1 wherein A is CR6, Z is nitrogen, G, D and E are all sp2 carbon.

### Claim 10 (depends on 1)

A nitrogen hexacycle compound according to claim 1 wherein R1 is not hydrogen but is a functional group or an aliphatic group optionally substituted by a functional group.

### Claim 11 (depends on 1)

A nitrogen hexacycle compound according to claim 1 wherein R1 is an aliphatic group selected from linear, branched or cyclic alkyl of 1 to 6 carbons, linear, branched or cyclic alkenyl of 2 to 6 carbons, linear, branched or cyclic alkoxyalkyl or alkoxyalkenyl of 2 to 6 carbons, the thia analog thereof, linear, branched or cyclic alkanoyl or alkenoyl of 2 to 6 carbons, linear, branched or cyclic alkanoylalkyl or alkenoylalkyl or 3 to 7 carbons, linear, branched or cyclic alkanoyloxy or alkanoyloxy of 2 to 6 carbons, or linear, branched or cyclic alkanoyloxyalkyl or alkenoyloxyalkyl of 3 to 7 carbons.

### Claim 12 (depends on 1)

A nitrogen hexacycle compound according to claim 1 wherein R1 is not hydrogen or an aliphatic group, but is a functional group that is polar and preferably is hydrogen bonding.

### Claim 13 (depends on 12)

A nitrogen hexacycle compound according to claim 12 wherein R1 is a polar, hydrogen bonding functional group.

### Claim 14 (depends on 13)

A nitrogen hexacycle compound according to claim 13 wherein R1 is selected from the group consisting of B(OH)2, B(OR)2 wherein R is an alkyl group of 1 to 6 carbons, ORd, (CH2)nORd, CN, SRd, OC(O)Rd, C(O)Rd, C(O)ORd, OC(O)N(Rd)2, C(O)N(Rd)2, N(Rd)C(O)ORd, N(Rd)C(O)Rd, —N(Rd)C(O)N(Rd)2, N(Rd)C(NRd)N(Rd)2, N(Rd)S(O)tRd, S(O)tORd, S(Ot)Rd, S(O)tN(Rd)2, N(Rd)2, (CH2)nN(Rd)2, PO3(Rd)2, C(O)Rd and CF3; each n is independently an integer of 1, 2 or 3, preferably 1; each t is independently an integer of 1 or 2, preferably 2; each Rd is independently hydrogen, alkyl of 1 to 6 carbons, fluoroalkyl of 1 to 6 carbons, carbocyclyl of 3 to 10 carbons, carbocyclylalkyl of 4 to 12 carbons, aryl of 6 to 10 carbons, aralkyl, heterocyclyl, heterocyclylalkyl, heteroaryl, heteroarylalkyl, alkenyl of 2 to 6 carbons, alkynyl or 2 to 6 carbons or any combination thereof, and Rd preferably is hydrogen or alkyl of 1 to 4 carbons, more preferably hydrogen or methyl, most preferably hydrogen.

### Claim 15 (depends on 14)

A nitrogen hexacycle compound according to claim 14 wherein Rd is hydrogen, phenyl or alkyl of 1 to 6 carbons, preferably 1 to 3 carbons, more preferably methyl or ethyl.

### Claim 16 (depends on 15)

A nitrogen hexacycle compound according to claim 15 wherein Rd is hydrogen.

### Claim 17 (depends on 15)

A nitrogen hexacycle compound according to claim 15 wherein Rd is methyl.

### Claim 18 (depends on 14)

A nitrogen hexacycle compound according to claim 14 wherein R1 is selected from the group consisting of boronic acid, boronic ester with the ester group being straight, branched or cyclic alkyl of 1 to 6 carbons, carboxylic acid, carboxyl ester with the ester group being straight, branched or cyclic alkyl of 1 to 6 carbons, carboxamide, N-alkyl carboxamide of 1 to 6 carbons in the straight, branched or cyclic alkyl group, sulfonic acid, sulfonyl ester with the ester group being straight, branched or cyclic alkyl of 1 to 6 carbons, sulfonamide, alkyl substituted sulfonamide with the alkyl group being straight, branched or cyclic of 1 to 6 carbons, amine (NH2), mono or dialkyl amine with the alkyl being straight, branched or cyclic of 1 to 6 carbons, N-alkyl amino methyl with the alkyl group being straight, branched or cyclic of 1 to 6 carbons, nitrile, or straight, branched or cyclic alkoxy of 1 to 6 carbons.

### Claim 19 (depends on 14)

A nitrogen hexacycle compound according to claim 14 wherein R1 is selected from the group consisting of boronic acid, boronic alkyl ester of 1 to 3 carbons in the alkyl group, carboxyl, sulfonoxy, carboxamide, sulfonamide, aminocarbonyl alkyl, aminosulfonylalkyl, amine, monoalkyl amine, hydroxyl, hydroxyalkyl, alkoxy, cyano, nitro, carboxylic ester, sulfonic ester, methylenyl or ethylenyl carboxylic acid or sulfonic acid, methylenyl or ethylenyl carboxylic or sulfonic ester, methylenyl or ethylenyl carboxamide or sulfonamide.

### Claim 20 (depends on 14)

A nitrogen hexacycle compound according to claim 14 wherein R1 is selected from the group consisting of from OMe, OEt, CN, V(CH2)mW, N(Ra)2, CO(NRa)2, B(OH)2, B(OR)2 wherein R is an alkyl group of 1 to 6 carbons, SO2Ra and SO2N(Ra)2; wherein each Ra independently is H, Me, Et; n is independently 0 or 1; m is 0, 1, 2 or 3; W is amino, alkylamino, alkoxy, carboxy, carboxylic acid, carboxamide, carboxyl ester or N-alkyl carboxamide, sulfonic acid, sulfonamide, boronic acid, boronic Me or Et ester; and V is O, S, NH, CO2, CONH and NH.

### Claim 21 (depends on 1)

A nitrogen hexacycle compound according to claim 1 wherein R2 and R2′ are each independently selected from the group consisting of hydrogen, linear, branched or cyclic alkyl or alkenyl of 1 to 6 carbons (2 minimum for alkenyl), halogen, B(OH)2, B(ORg) wherein Rg is an alkyl of 1 to 3 carbons, ORd, CN, SRd, OC(O)Rd, C(O)Rd, C(O)ORd, OC(O)N(Rd)2, C(O)N(Rd)2, N(Rd)C(O)ORd, N(Rd)C(O)Rd, N(Rd)C(O)N(Rd)2, N(Rd)C(NRd)N(Rd)2, N(Rd)S(O)tRd, S(O)tORd, S(O)tN(Rd)2, N(Rd)2, (CH2)tN(Rd)2 and PO3(Rd)2 wherein each Rd is independently hydrogen, alkyl, fluoroalkyl, carbocyclyl, carbocyclylalkyl, aryl, aralkyl, heterocyclyl, heterocyclylalkyl, heteroaryl, heteroarylalkyl alkenyl, alkynyl or any combination thereof; each t is independently selected from the group of integers of 1 and 2; each q is independently an integer of 0, 1, 2 or 3; n is an integer of 0, 1 or 2, preferably 1, more preferably 0, and Rd preferably is hydrogen or alkyl of 1 to 4 carbons, more preferably hydrogen or methyl, most preferably hydrogen.

### Claim 22 (depends on 21)

A nitrogen hexacycle compound according to claim 21 wherein Rd is hydrogen, phenyl or alkyl of 1 to 6 carbons, preferably 1 to 3 carbons, more preferably methyl or ethyl.

### Claim 23 (depends on 21)

A nitrogen hexacycle compound according to claim 21 wherein Rd is hydrogen.

### Claim 24 (depends on 21)

A nitrogen hexacycle compound according to claim 21 wherein Rd is methyl.

### Claim 25 (depends on 21)

A nitrogen hexacycle compound according to claim 21 wherein R2 and R2′ are each independently selected from the group consisting of hydrogen, halogen, straight, branched or cyclic alkyl of 1 to 6 carbons, B(OH)2, B(OR)2 wherein R is an alkyl group of 1 to 6 carbons, carboxylic acid, carboxyl ester with the ester group being straight, branched or cyclic alkyl of 1 to 6 carbons, N-alkyl amino methyl with the alkyl group being straight, branched or cyclic of 1 to 6 carbons, sulfonic acid, sulfonyl ester with the ester group being straight, branched or cyclic alkyl of 1 to 6 carbons, sulfonamide, amine (NH2), mono, di or trialkyl amine with the alkyl being straight, branched or cyclic of 1 to 6 carbons, nitrile, carboxamide, N-alkyl carboxamide of 1 to 6 carbons in the straight, branched or cyclic alkyl group, perfluoroalkyl of 1 to 3 carbons, and straight, branched or cyclic alkoxy of 1 to 6 carbons.

### Claim 26 (depends on 1)

A nitrogen hexacycle compound according to claim 1 wherein Rn, R4 and each of R5 are each independently selected from hydrogen, halogen, straight or branched alkyl of 1 to 6 carbons, carboxylic acid, carboxamide, substituted aminomethyl, sulfonic acid, sulfonamide, amine, mono, di or trialkyl amine of 1 to 6 carbons, nitrile, N-alkyl carboxamide of 1 to 6 carbons in the alkyl group, perfluoroalkyl of 1 to 3 carbons, alkoxy of 1 to 6 carbons, boronic acid or boronic ester having 1 to 3 carbons in the ester group.

### Claim 27 (depends on 26)

A nitrogen hexacycle compound according to claim 26 wherein n of Rn is 0, R3 is hydrogen or methyl, R4 and R5 are each independently hydrogen or methyl, and R2 and R2′ are each independently selected from H, Me, Et, propyl (Pr), isopropyl (iPr), butyl (Bu), isobutyl (iBu), OMe, OEt, CN, OCH2CH2X, N(Ra)2, CO(NRa)2, B(OH)2, B(OR)2 wherein R is an alkyl group of 1 to 6 carbons, SO2Ra, SO2N(Ra)2; Ra is H, Me, Et, Ph and when two Ra's are present, each is selected independently; and X is amino, alkylamino, alkoxy, carboxy, carboxamide, carboxyl ester or N-alkyl carboxyamide.

### Claim 28 (depends on 27)

A nitrogen hexacycle compound according to claim 27 wherein:
R1 is B(OH)2, B(OMe or Et)2, CONH2, CN, SO2NH2, COOH, COOMe, COOEt, CH2NH2, CH2NHCOCH3, CH2NHSO2CH3 or CH2OH; R2 and R2′ are each independently H, Me, Et, COOH, CONH2, SO3H, SO2NH2, B(OH)2, B(OMe or Et)2, OMe, OEt, CN, F, Cl or Br, most especially, H or Me and of these two substituents, preferably H; R3 is H, Me, Et, COMe, COEt, SO2Me or SO2Et, most especially H or Me and of these two substituents, preferably H; R4 and each of R5 are each independently H, Me or Et, most especially H; Rn is excluded by n as 0; R6 is hydrogen.

### Claim 29 (depends on 1)

A nitrogen hexacycle compound according to claim 1 wherein Ar is phenyl or substituted phenyl with the substituent being is fluoro, trifluoromethyl, boronic acid, boronic alkyl ester with a C1 to C6 alkyl, carboxylic acid, carboxylic alkyl ester with a C1 to C6 alkyl, carboxyamide, sulfonic acid, sulfonamide; preferably fluoro, boronic acid, boronic ester, carboxylic acid, carboxamid, sulfonic acid, sulfonic ester; more preferably fluoro, boronic acid, carboxylic acid, sulfonic acid; most preferred fluoro or boronic acid.

### Claim 30 (depends on 29)

A nitrogen hexacycle compound according to claim 29 wherein Ar is phenyl, phenyl-4-boronic acid or 4-fluorophenyl.

### Claim 31 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30)

A nitrogen hexacycle compound according to claim 1 wherein the P2 group is one of Formulas IA, ID, IE, IG, IH, IK, IK-sat, JO, IP, IS, IT, IU, IW, IX, IY and IZ-2 and the substituents R1 through R6 and Rn are present, are delineated as given by any one of claims 1-30 and are positioned as given in Formula I:

### Claim 32 (depends on 1)

A nitrogen hexacycle compound according to claim 1 wherein Q1 and Q2− are both nitrogen as shown by formulas NT5 and NT6 wherein the upper right arrow designates the P2 group position and the bottom arrow designates the P4 group position:

### Claim 33 (depends on 1)

A pharmaceutical composition comprising a pharmaceutically acceptable carrier and an amount of a compound according to claim 1 which is effective as an inhibitor of the AAA family member Valosin containing protein.

### Claim 34 (depends on 33)

A pharmaceutical composition according to claim 33 wherein the Valosin containing protein is in a human cell.

### Claim 35 (depends on 1)

A method of decreasing Valosin containing protein activity or decreasing degradation of a proteasome system substrate comprising administering to a patient an effective amount of a compound according to claim 1.

### Claim 36 (depends on 33)

A method of decreasing Valosin containing protein activity or degradation of a proteasome system substrate comprising administering to a patient an effective amount of a pharmaceutical composition of claim 33.

### Claim 37 (depends on 35)

A method according to claim 35 wherein the patient is a human.

### Claim 38 (depends on 1)

A method for treatment of a neoplastic malcondiction associated with Valosin containing protein comprising administering to a patient in need thereof an effective amount of a compound according to claim 1.

### Claim 39 (depends on 33)

A method for treatment of a neoplastic malcondiction associated with Valosin containing protein comprising administering to a patient in need thereof an effective amount of a pharmaceutical composition according to claim 33.

### Claim 40 (depends on 1)

A compound according to claim 1 having the IUPAC name:
1-(5-(benzylamino)-6-ethyl-1,2,4-triazin-3-yl)-1H-indazole-4-carboxamide
1-(5-(benzylamino)-6-methyl-1,2,4-triazin-3-yl)-1H-indazole-4-carboxamide
3-(4-((3-fluorobenzyl)amino)-6-ethyl-1,3,5-triazin-2-yl)-1H-indazole-7-carboxamide
3-(4-(benzylamino)-6-ethyl-1,3,5-triazin-2-yl)-1H-indazole-7-carboxamide
3-(4-((3-fluorobenzyl)amino)-6-methyl-1,3,5-triazin-2-yl)-1H-indazole-7-carboxamide
3-(4-(benzylamino)-6-methyl-1,3,5-triazin-2-yl)-1H-indazole-7-carboxamide
(1-(5-((3-fluorobenzyl)amino)-6-ethyl-1,2,4-triazin-3-yl)-2-methyl-1H-indole-4-yl)boronic acid
(1-(5-(benzylamino)-6-ethyl-1,2,4-triazin-3-yl)-2-methyl-1H-indole-4-yl)boronic acid
(3-(((3-(4-carbamoyl-2-methyl-1H-indol-1-yl)-6-ethyl-1,2,4-triazin-5-yl)amino)methyl)phenyl)boronic acid
1-(5-((3-fluorobenzyl)amino)-6-ethyl-1,2,4-triazin-3-yl)-2-methyl-1H-indole-4-carboxamide
1-(5-(benzylamino)-6-ethyl-1,2,4-triazin-3-yl)-2-methyl-1H-indole-4-carboxamide
(1-(5-((3-fluorobenzyl)amino)-6-methyl-1,2,4-triazin-3-yl)-2-methyl-1H-indole-4-yl)boronic acid
(1-(5-(benzylamino)-6-methyl-1,2,4-triazin-3-yl)-2-methyl-1H-indole-4-yl)boronic acid
(3-(((3-(4-carbamoyl-2-methyl-1H-indol-1-yl)-6-methyl-1,2,4-triazin-5-yl)amino)methyl)phenyl)boronic acid
1-(5-((3-fluorobenzyl)amino)-6-methyl-1,2,4-triazin-3-yl)-2-methyl-1H-indole-4-carboxamide
1-(5-(benzylamino)-6-methyl-1,2,4-triazin-3-yl)-2-methyl-1H-indole-4-carboxamide
(1-(4-((3-fluorobenzyl)amino)-6-ethyl-1,3,5-triazin-2-yl)-2-methyl-1H-indol-4-yl)boronic acid
(1-(4-(benzylamino)-6-ethyl-1,3,5-triazin-2-yl)-2-methyl-1H-indol-4-yl)boronic acid
(3-(((4-(4-carbamoyl-2-methyl-1H-indol-1-yl)-6-ethyl-1,3,5-triazin-2-yl)amino)methyl)phenyl)boronic acid
1-(4-((3-fluorobenzyl)amino)-6-ethyl-1,3,5-triazin-2-yl)-2-methyl-1H-indole-4-carboxamide
1-(4-(benzylamino)-6-ethyl-1,3,5-triazin-2-yl)-2-methyl-1H-indole-4-carboxamide
1-(4-((3-fluorobenzyl)amino)-6-ethyl-1,3,5-triazin-2-yl)-2-methyl-1H-indole-4-sulfonamide
1-(4-(benzylamino)-6-ethyl-1,3,5-triazin-2-yl)-2-methyl-1H-indole-4-sulfonamide
(1-(4-((3-fluorobenzyl)amino)-6-methyl-1,3,5-triazin-2-yl)-2-methyl-1H-indol-4-yl)boronic acid
(1-(4-(benzylamino)-6-methyl-1,3,5-triazin-2-yl)-2-methyl-1H-indol-4-yl)boronic acid
(3-(((4-(4-carbamoyl-2-methyl-1H-indol-1-yl)-6-methyl-1,3,5-triazin-2-yl)amino)methyl)phenyl)boronic acid
1-(4-((3-fluorobenzyl)amino)-6-methyl-1,3,5-triazin-2-yl)-2-methyl-1H-indole-4-carboxamide
1-(4-(benzylamino)-6-methyl-1,3,5-triazin-2-yl)-2-methyl-1H-indole-4-carboxamide
1-(4-((3-fluorobenzyl)amino)-6-methyl-1,3,5-triazin-2-yl)-2-methyl-1H-indole-4-sulfonamide
1-(4-(benzylamino)-6-methyl-1,3,5-triazin-2-yl)-2-methyl-1H-indole-4-sulfonamide
3-(5-(benzylamino)-6-ethyl-1,2,4-triazin-3-yl)-2-methyl-1H-indole-7-carboxamide
3-(5-(benzylamino)-6-methyl-1,2,4-triazin-3-yl)-2-methyl-1H-indole-7-carboxamide
3-(4-((3-fluorobenzyl)amino)-6-ethyl-1,3,5-triazin-2-yl)-2-methyl-1H-indole-7-carboxamide
3-(4-(benzylamino)-6-ethyl-1,3,5-triazin-2-yl)-2-methyl-1H-indole-7-carboxamide
3-(4-((3-fluorobenzyl)amino)-6-methyl-1,3,5-triazin-2-yl)-2-methyl-1H-indole-7-carboxamide
3-(4-(benzylamino)-6-methyl-1,3,5-triazin-2-yl)-2-methyl-1H-indole-7-carboxamide
1-(5-(benzylamino)-6-ethyl-1,2,4-triazin-3-yl)-2-methoxy-1H-benzo[d]imidazole-4-carboxamide
1-(5-(benzylamino)-6-methyl-1,2,4-triazin-3-yl)-2-methoxy-1H-benzo[d]imidazole-4-carboxamide
1-(4-((3-fluorobenzyl)amino)-6-ethyl-1,3,5-triazin-2-yl)-2-methoxy-1H-benzo[d]imidazole-4-carboxamide
1-(4-(benzylamino)-6-ethyl-1,3,5-triazin-2-yl)-2-methoxy-1H-benzo[d]imidazole-4-carboxamide
1-(4-((3-fluorobenzyl)amino)-6-methyl-1,3,5-triazin-2-yl)-2-methoxy-1H-benzo[d]imidazole-4-carboxamide, or
1-(4-(benzylamino)-6-methyl-1,3,5-triazin-2-yl)-2-methoxy-1H-benzo[d]imidazole-4-carboxamide.
